新股消息 | 上海生生递表港交所

Group 1 - The core viewpoint of the article is that Shanghai Shengsheng Pharmaceutical Cold Chain Technology Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, with CICC and Guotai Junan Securities (Hong Kong) as joint sponsors [1] - Shanghai Shengsheng is recognized as a leading integrated temperature-controlled supply chain service provider in the pharmaceutical and life sciences industry in China, focusing on temperature-controlled supply chain services for clinical trials and extending to commercialized medical product services [1] - According to a report by Frost & Sullivan, Shanghai Shengsheng ranks first in the Chinese market for pharmaceutical and life sciences temperature-controlled supply chain services and is the only Chinese company among the top ten global clinical trial temperature-controlled supply chain service providers [1]